UY24668A1 - Metodo para producir lineas de celulas inmortalizadas para crecimiento de virus - Google Patents

Metodo para producir lineas de celulas inmortalizadas para crecimiento de virus

Info

Publication number
UY24668A1
UY24668A1 UY24668A UY24668A UY24668A1 UY 24668 A1 UY24668 A1 UY 24668A1 UY 24668 A UY24668 A UY 24668A UY 24668 A UY24668 A UY 24668A UY 24668 A1 UY24668 A1 UY 24668A1
Authority
UY
Uruguay
Prior art keywords
cells
culture
virus
unaged
cell
Prior art date
Application number
UY24668A
Other languages
English (en)
Inventor
N Foster Douglas
K Foster Linda
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of UY24668A1 publication Critical patent/UY24668A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/867—Retroviral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16651—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Método para producir una línea de células inmortalizadas de fibroblastos embriónicos de pollo comprendiendo los pasos de: hacer fibroblastos primarios de pollo en cultivo; pasando los fibroblastos en cultivo hasta iniciar el envejecimiento de la célula; concentrando las células durante el envejecimiento de las células para mantener de 30 a 60% de la confluencia el cultivo; identificando el foci de las células no envejecidas; y haciendo crecer las células no envejecidas por más de 30 pasajes. En particular se reivindica el método donde las líneas de células son UMNSAH y depositadas en la colección Americana de Cultivos tipo como accesión NºCRL-12203, en el cultivo; infectar las células con el virus; permitir que el virus repliegue en las células; y recoger el virus que replegó las células.
UY24668A 1996-08-13 1997-08-13 Metodo para producir lineas de celulas inmortalizadas para crecimiento de virus UY24668A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/696,200 US5672485A (en) 1996-08-13 1996-08-13 Immortalized cell lines for virus growth

Publications (1)

Publication Number Publication Date
UY24668A1 true UY24668A1 (es) 1998-02-02

Family

ID=24796108

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24668A UY24668A1 (es) 1996-08-13 1997-08-13 Metodo para producir lineas de celulas inmortalizadas para crecimiento de virus

Country Status (29)

Country Link
US (4) US5672485A (es)
EP (1) EP0920491B1 (es)
JP (3) JP3754088B2 (es)
KR (1) KR100375871B1 (es)
CN (1) CN1228119B (es)
AR (1) AR008294A1 (es)
AT (1) ATE362524T1 (es)
AU (1) AU726820B2 (es)
BR (1) BR9711067A (es)
CA (1) CA2263725C (es)
CO (1) CO4700552A1 (es)
DE (1) DE69737735T2 (es)
DK (1) DK0920491T3 (es)
DZ (1) DZ2291A1 (es)
ES (1) ES2285738T3 (es)
GT (1) GT199700091A (es)
HK (1) HK1022496A1 (es)
HN (1) HN1997000124A (es)
HU (1) HU226658B1 (es)
IL (4) IL128511A (es)
MA (1) MA24303A1 (es)
MY (1) MY125594A (es)
NZ (1) NZ334147A (es)
PE (1) PE108198A1 (es)
PT (1) PT920491E (es)
SV (1) SV1997000071A (es)
UY (1) UY24668A1 (es)
WO (1) WO1998006824A1 (es)
ZA (1) ZA977216B (es)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth
US6150505A (en) * 1997-09-19 2000-11-21 Hadasit Medical Research Services & Development Ltd. Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII
US6821741B1 (en) 2001-04-27 2004-11-23 University Hospitals Of Cleveland Cells for detection of enteroviruses
US6552172B2 (en) * 2001-08-30 2003-04-22 Habto Biotech, Inc. Fibrin nanoparticles and uses thereof
US20040023358A1 (en) * 2001-12-21 2004-02-05 Wyeth Avian embryo particulate biomass for the production of virus antigens
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
US20090217404A1 (en) * 2002-09-27 2009-08-27 Lowe Scott W Cell-based RNA interference and related methods and compositions
US7410557B2 (en) * 2002-09-30 2008-08-12 Honda Motor Co., Ltd. Hydrogen activating apparatus
WO2004056977A1 (en) * 2002-12-13 2004-07-08 Aventis Pasteur, Inc. Production of alvac on avian embryonic stem cells
US20090186839A1 (en) * 2003-02-17 2009-07-23 Cold Spring Harbor Laboratory Model for studying the role of genes in chemoresistance
WO2004074445A2 (en) * 2003-02-17 2004-09-02 Cold Spring Harbor Laboratory Model for studying the role of genes in tumor resistance to chemotherapy
US20050198700A1 (en) * 2003-03-07 2005-09-08 Avigenics, Inc. Genomic modification
US20040255345A1 (en) * 2003-03-07 2004-12-16 Rapp Jeffrey C. Production of transgenic avians
US20050034186A1 (en) * 2003-03-07 2005-02-10 Harvey Alex J. Site specific nucleic acid integration
EP1608219A4 (en) * 2003-03-07 2007-03-14 Avigenics Inc AVIAN TRANSGENESIS MEDIATED BY INTEGRASE
US20050273873A1 (en) * 2003-03-07 2005-12-08 Avigenics, Inc. Genomic modification
US7432101B2 (en) 2003-07-22 2008-10-07 Vivalis Production of poxviruses with adherent or non adherent avian cell lines
US20070275010A1 (en) * 2003-09-18 2007-11-29 Mark Feinberg Mva Vaccines
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
US20060123504A1 (en) * 2004-12-07 2006-06-08 Avigenics, Inc. Methods of producing polyclonal antibodies
US20060174364A1 (en) * 2004-03-01 2006-08-03 Avigenics, Inc. Artificial chromosomes and transchromosomic avians
WO2006042214A1 (en) * 2004-10-08 2006-04-20 Avigenics, Inc. Modified integrase and methods of use
US8137907B2 (en) * 2005-01-03 2012-03-20 Cold Spring Harbor Laboratory Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
US20070044164A1 (en) * 2005-05-31 2007-02-22 Cold Spring Harbor Laboratory Methods for producing microRNAs
TR201909425T4 (tr) * 2005-10-05 2019-07-22 Alexion Pharma Inc Yüksek ti̇treli̇ vi̇rüsün hizli üreti̇mi̇
CA2656259C (en) 2006-06-20 2013-03-19 Transgene S.A. Process for producing poxviruses and poxvirus compositions
CN100443588C (zh) * 2006-12-11 2008-12-17 中国农业科学院北京畜牧兽医研究所 静宁鸡胚成纤维细胞系及其培养方法
US8213704B2 (en) * 2007-05-09 2012-07-03 Kla-Tencor Corp. Methods and systems for detecting defects in a reticle design pattern
EP2014279A1 (en) * 2007-06-22 2009-01-14 Pevion Biotech AG Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
JP5421250B2 (ja) 2007-07-03 2014-02-19 トランスジーン ソシエテ アノニム トリ不死化細胞株
US8357531B2 (en) * 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
WO2009055724A2 (en) * 2007-10-26 2009-04-30 Cold Spring Harbor Laboratory High throughput methods for functionally determining rna interference efficiency
CA2715719C (en) * 2008-02-25 2019-08-06 Baxter International Inc. Method for producing continuous cell lines
JP2012526532A (ja) 2009-05-12 2012-11-01 トランジェーヌ、ソシエテ、アノニム 不死化鳥類細胞系およびその用途
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
DK2596099T3 (da) 2010-07-20 2020-02-24 Bavarian Nordic As Fremgangsmåde til høst af ekspressionsprodukter
FR3008992A1 (fr) 2013-07-25 2015-01-30 Agronomique Inst Nat Rech Procede de selection d'une lignee cellulaire permissive pour la replication de virus aviaires
EP3226894B1 (en) 2014-12-01 2019-08-07 Transgene SA Stable liquid vaccinia virus formulations
PL3227433T3 (pl) * 2014-12-04 2019-01-31 Intervet International B.V. Unieśmiertelnione fibroblasty zarodków kurzych
KR101768581B1 (ko) * 2015-08-13 2017-08-17 전북대학교 산학협력단 자발적 불멸화된 체세포의 단일 세포로부터 리프로그래밍 세포주의 제조방법
US20190144831A1 (en) * 2015-12-11 2019-05-16 Intervet Inc. Immortalised chicken embryonic epithelial kidney cells
WO2017191147A1 (en) 2016-05-04 2017-11-09 Transgene Sa Combination therapy with cpg tlr9 ligand
EP3522920A2 (en) 2016-10-10 2019-08-14 Transgene SA Immunotherapeutic product and mdsc modulator combination therapy
US20200179507A1 (en) 2016-11-17 2020-06-11 Regents Of The University Of Minnesota Immortalized cell lines and methods of use
AU2018269319A1 (en) 2017-05-15 2019-11-07 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
CA3062549A1 (en) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
AU2018287159A1 (en) 2017-06-21 2020-01-16 Transgene Personalized vaccine
CN107858323B (zh) * 2017-11-08 2020-10-09 广东省生物资源应用研究所 一种红耳龟胚胎成纤维细胞系及其构建方法
CN109234239B (zh) * 2018-07-13 2021-09-14 广东永顺生物制药股份有限公司 一种鸭瘟病毒的培养方法
US20210187100A1 (en) 2018-09-06 2021-06-24 Bavarian Nordic A/S Storage Improved Poxvirus Compositions
US20230031097A1 (en) 2019-12-20 2023-02-02 Intervet Inc. Multivalent hvt vector vaccine
CN115243717A (zh) 2020-03-12 2022-10-25 巴法里安诺迪克有限公司 改善痘病毒稳定性的组合物
AU2021309007A1 (en) 2020-07-13 2023-02-16 Transgene Treatment of immune depression
CA3190070A1 (en) 2020-09-07 2022-03-10 Martijn Alexander LANGEREIS Ha stem vaccine for ha antibody-positive targets
CN116648259A (zh) 2020-12-24 2023-08-25 英特维特国际股份有限公司 多价hvt载体疫苗
EP4370150A1 (en) 2021-07-13 2024-05-22 Intervet International B.V. Overcoming antibody-interference in avians
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
WO2023213946A1 (en) 2022-05-05 2023-11-09 Intervet International B.V. New multivalent hvt vector vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3058438B2 (ja) * 1990-10-19 2000-07-04 財団法人化学及血清療法研究所 ヒト肝臓組織特異的ウイルスの感染可能な霊長類の不死化肝細胞およびその調製方法
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth

Also Published As

Publication number Publication date
JP2005118053A (ja) 2005-05-12
JP3754088B2 (ja) 2006-03-08
WO1998006824A1 (en) 1998-02-19
US5985642A (en) 1999-11-16
US5672485A (en) 1997-09-30
CA2263725C (en) 2002-10-15
ZA977216B (en) 1998-02-19
CA2263725A1 (en) 1998-02-19
MY125594A (en) 2006-08-30
IL158301A0 (en) 2004-05-12
DE69737735T2 (de) 2008-01-31
KR20000029968A (ko) 2000-05-25
HUP0000188A3 (en) 2005-11-28
JP2006320328A (ja) 2006-11-30
US6207415B1 (en) 2001-03-27
ES2285738T3 (es) 2007-11-16
IL128511A (en) 2004-06-01
NZ334147A (en) 2000-08-25
DK0920491T3 (da) 2007-09-17
AU726820B2 (en) 2000-11-23
KR100375871B1 (ko) 2003-03-10
PE108198A1 (es) 1999-01-21
PT920491E (pt) 2007-07-27
IL158302A0 (en) 2004-05-12
SV1997000071A (es) 2000-07-06
IL128511A0 (en) 2000-01-31
HK1022496A1 (en) 2000-08-11
EP0920491A1 (en) 1999-06-09
US5879924A (en) 1999-03-09
GT199700091A (es) 1997-08-12
HUP0000188A2 (hu) 2000-06-28
CN1228119B (zh) 2012-04-04
EP0920491B1 (en) 2007-05-16
DE69737735D1 (de) 2007-06-28
BR9711067A (pt) 1999-08-17
ATE362524T1 (de) 2007-06-15
AR008294A1 (es) 1999-12-29
IL158303A0 (en) 2004-05-12
HN1997000124A (es) 1999-03-19
MA24303A1 (fr) 1998-04-01
HU226658B1 (en) 2009-06-29
AU4069197A (en) 1998-03-06
DZ2291A1 (fr) 2002-12-25
JP2000516095A (ja) 2000-12-05
CO4700552A1 (es) 1998-12-29
CN1228119A (zh) 1999-09-08

Similar Documents

Publication Publication Date Title
UY24668A1 (es) Metodo para producir lineas de celulas inmortalizadas para crecimiento de virus
ATE253112T1 (de) Menschliche hematopoietische stammzellen
ES2147720T3 (es) Factor de celulas madre.
ATE252634T1 (de) Herstellung eines zusammenziehbaren glatten muskels
DK1155116T3 (da) Anvendelse af kollagenase i fremstillingen af kulturer af neurale stamceller
ATE408004T1 (de) Vögelzell-linien und deren verwendung zur herstellung interessanter biologischer substanzen
DE69637656D1 (de) Methoden zur Züchtung von Tierzellen
ATE174058T1 (de) Herstellung von proteinen mittels homologer rekombination
ATE124995T1 (de) Pflanzengewebekulturverfahren zur transformation von pflanzenzellen.
MX9207397A (es) Recipientes para cultivo de celulas que tienen hileras interiores y metodo para cultivar celulas en los mismos.
ATE27463T1 (de) Verfahren zur in vitro transformation von pflanzenprotoplasten mit plasmid-dns.
GR3034195T3 (en) New cultures of keratinocytes, process for their preparation and their use as wound healing substances.
ATE153214T1 (de) Medien zur zellzucht und verfahren dazu
ATE348876T1 (de) Verfahren zur vermehrung von natürlichen killerzellen
DE69732792D1 (de) Verfahren zur herstellung parthenokarper oder weiblich-steriler transgener pflanzen
AU551487B2 (en) Culturing human cells in algae extract
AR005823A1 (es) Proceso para producir un virus varicela zoster libre de celulas
Heimann et al. Rat esophageal and epidermal keratinocytes: intrinsic differences in culture and derivation of continuous lines
DE3666458D1 (en) Method and device for the _i(in vitro) culture of plant cells and organs, as well as for the micropropagation and regeneration of complete plants
DE60035515D1 (de) Hohe zytokinproduktion mit verbesserte zelllebensfähigkeit
CN109402045A (zh) 一种水牛精原干细胞样细胞的体外培养及传代方法
Arase et al. Culture of human outer root sheath cells from plucked hair follicles in serum-free conditions
ES2191064T3 (es) Procedimiento para producir proteinas.
NO991211D0 (no) Apparat for dyrking av mikroorganismer
BE904804A (fr) Production et utilisation d'un colorant naturel rouge a intensite elevee derive de cultures de tissu cellulaire de carotte.

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20170813